Ruthenium complexes for treating cancer which comprises cancer stem cells

The invention relates to ruthenium complexes for treating cancer which comprises cancer stem cells. The present invention relates to the use of ruthenium(II) complexes to prepare a medicinal product for treating cancer, especially cancer which comprises cancer stem cells. Said ruthenium complexes are able to selectively metallate the guanine quadruplexes, thus resulting in increased expression of the c-MYC oncogene. Said increase in the proportion of c-MYC may promote the differentiation of cancer stem cells.  
Grupo de investigación: